Valiant Laboratories Rights Issue 2025 Details, Record Date, Issue Price

Valiant Laboratories Rights Issue details are now available. The company is issuing 1,08,62,500 equity shares amounting to Rs 81.47 crores. Valiant Laboratories Rights Issue price is Rs 75 per share, and the face value is Rs 10 per share.

Valiant Laboratories Rights Issue open date is July 28, 2025, and the closing date is August 8, 2025. Valiant Laboratories rights issue entitlement ratio is 1:4, which is 1 Rights Equity Shares for every 4 fully paid-up Equity Shares held on the record date.

Valiant Laboratories Rights Issue record date is July 19, 2025. The last date to buy shares of Valiant Laboratories is July 17, 2025. This Rights Issue subscription status will be available soon.

Valiant Laboratories Rights Issue Allotment date, Credit date, and the Listing date will be available soon. However, the listing will be on the BSE and NSE platforms.

Valiant Laboratories Limited's rights issue registrar is MUFG Intime India Private Limited, and the book-running lead manager(s) have not yet been disclosed.

Also Read | Mahindra Logistics Rights Issue 2025 Details, Record Date

Valiant Laboratories Rights Issue Details

Valiant Laboratories Rights Issue details are as follows: The Company plans to issue 1,08,62,500 equity shares, aggregating the total amount of Rs 81.47 crores. Valiant Laboratories Rights issue price is Rs 75 per share. The rights issue entitlement ratio is 1:4, which is 1 Rights Equity Shares for every 4 fully paid-up equity share(s).

Valiant Laboratories Rights Issue Dates

Valiant Laboratories Rights issue record date is July 19, 2025, and the last date to buy shares of Valiant Laboratories is July 17, 2025.

Valiant Laboratories Rights Issue Subscription

Valiant Laboratories Rights Issue subscription starts on July 28, 2025. The details of the Rights Issue entitlement are 1 Rights Equity Share(s) for every 4 fully paid-up Equity Share(s) held on the Record Date. Valiant Laboratories issue price is Rs 75 per share.

Valiant Laboratories Limited: About the Company

Valiant Laboratories Limited, started in 1980, is a leading producer of active pharmaceutical ingredients (APIs), focused mainly on the production of bulk Paracetamol (acetaminophen) drug substance. 

Originally established as Bharat Chemicals, the company transformed into a public limited company in August 2021, which represents its growth within the pharmaceutical sector. 

Valiant Laboratories has a state-of-the-art manufacturing facility located in Palghar, Maharashtra, with an annual installed capacity of 9,000 MT, and is equipped with sophisticated instrumentation to ensure reliability, safety, and quality for our customers. 

Valiant also has a completely independent research and development centre to drive our company’s new product development initiatives to support our customers' constantly evolving needs. 

The company's greatest strength is its commitment to develop and use stringent compliance standards and continual processing improvement to support reliable supply of high-quality APIs to pharmaceutical partners in India and worldwide. 

As part of the Aarti Group of Companies, Valiant Laboratories can leverage the decades of experiential expertise of our owners to better adapt to our evolving markets and participate in further business development opportunities to support and openly nurture sustainable practices to support the global healthcare market with consistent and safe pharmaceutical ingredient supply.

Valiant Laboratories Limited Financials (Amount in Rs crore)

Valiant Laboratories Rights Issue Registrar

Valiant Laboratories Limited's rights issue registrar is MUFG Intime India Private Limited, and the book-running lead manager(s) for this rights issue have not yet been disclosed. 

FAQs

1. What are the details of the Valiant Laboratories Rights Issue?

Valiant Laboratories Rights Issue details are as follows: Valiant Laboratories plans to issue 1,08,62,500 equity shares amounting to Rs 81.47 crores. Valiant Laboratories Rights issue price is Rs 75 per share, and the face value is Rs 10 per share. The rights issue entitlement ratio is 1:4, which is 1 Rights Equity Share(s) for every 4 fully paid-up equity share(s).

2. Valiant Laboratories Rights Issue open date and close date?

Valiant Laboratories Rights Issue's open date is July 28, 2025, and the closing date is August 8, 2025. Valiant Laboratories Rights Issue record date is July 19, 2025. The last date to buy shares of Valiant Laboratories is July 17, 2025.

3. How can I apply for the Valiant Laboratories Rights Issue?

You can apply for Valiant Laboratories in two ways: one is Net Banking (ASBA), and the other is by visiting the Registrar's Website (R-WAP Facility).

4. What is the entitlement ratio for the Valiant Laboratories Rights Issue?

Valiant Laboratories rights issue entitlement ratio is 1:4, which is 1 Rights Equity Share(s) for every 4 fully paid-up equity share(s).

5. How can I check the Spandana Sphoorty rights issue Allotment Status?

The registrar for this upcoming rights issue is MUFG Intime India Private Limited. On the allotment status date, investors can check the allotment status by visiting the registrar's website.

6. From where can I get the Letter of Offer for the Valiant Laboratories Rights issue?

You can download the Valiant Laboratories Rights Issue Letter of Offer by visiting here.

7. What is the listing date of the Valiant Laboratories Rights Issue?

The Valiant Laboratories Rights Issue listing date is not yet available. However, the listing will be on the BSE and NSE exchanges.

8. Who are the registrar and lead managers of the Valiant Laboratories Rights Issue?

Valiant Laboratories Limited's rights issue registrar is MUFG Intime India Private Limited, and the book-running lead manager(s) for this rights issue have not yet been disclosed.

Also Read | Exicom Tele-Systems Rights Issue 2025 Details, Record Date, Issue Price